ao link
Business Reporter
Business Reporter
Business Reporter
Search Business Report
My Account
Remember Login
My Account
Remember Login

End-To-End Workflow Solutions for Short Nucleic Acids and mRNA Analysis

Sponsored by Agilent
Linked InXFacebook
© 2025, Agilent. All rights reserved.

The explosion in demand for mRNA vaccines, CRISPR tools and short RNA therapies has made reliable oligonucleotide analysis more important than ever. Agilent’s workflow guide for short nucleic acids and mRNA delivers practical solutions for every step of development and quality control.

 

From high-resolution capillary electrophoresis to LC/MS and UV/Vis quantification, discover how to ensure the purity, size and integrity of your nucleic acid samples. Whether you’re working with siRNA, aptamers or mRNA vaccines, this guide will help you optimise your process from R&D to production.

 

Download resource guide

Sponsored by Agilent
Linked InXFacebook
Business Reporter

Winston House, 3rd Floor, Units 306-309, 2-4 Dollis Park, London, N3 1HF

23-29 Hendon Lane, London, N3 1RT

020 8349 4363

© 2025, Lyonsdown Limited. Business Reporter® is a registered trademark of Lyonsdown Ltd. VAT registration number: 830519543